Dianthus Therapeutics, Inc.
DE ˙ DB ˙ US2528281080
72,00 € ↑2,50 (3,60%)
2026-06-04
CENA AKCJI
SecurityDE:87E / Dianthus Therapeutics, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership261,962 shares
Latest Disclosed Value $ 21,983,851
Millennium Management Llc reports 60.74% decrease in ownership of 87E / Dianthus Therapeutics, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 261,962 shares of Dianthus Therapeutics, Inc. (DE:87E) valued at $18,206,359 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 667,216 shares of Dianthus Therapeutics, Inc.. This represents a change in shares of -60.74% during the quarter. The current value of the position is $18,861,264 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F DIANTHUS THERAPEUTICS COM 252828108 261,962 -405,254 -60.74 21,984 -20.05 0.0091
2026-02-17 2025-12-31 13F DIANTHUS THERAPEUTICS COM 252828108 667,216 521,050 356.48 27,496 378.09 0.0116
2025-11-14 2025-09-30 13F DIANTHUS THERAPEUTICS COM 252828108 146,166 -49,191 -25.18 5,752 58.04 0.0025
2025-08-14 2025-06-30 13F DIANTHUS THERAPEUTICS COM 252828108 195,357 195,357 3,640 0.0018
2025-05-15 2025-03-31 13F DIANTHUS THERAPEUTICS COM 252828108 0 -90,436 -100.00 0 -100.00
2025-02-14 2024-12-31 13F DIANTHUS THERAPEUTICS COM 252828108 90,436 55,682 160.22 1,972 107.26 0.0010
2024-11-14 2024-09-30 13F DIANTHUS THERAPEUTICS COM 252828108 34,754 34,754 952 0.0005
2024-08-14 2024-06-30 13F DIANTHUS THERAPEUTICS COM 252828108 0 -277,213 -100.00 0 -100.00
2024-05-15 2024-03-31 13F DIANTHUS THERAPEUTICS COM 252828108 277,213 243,249 716.20 8,316 2,255.81 0.0036
2024-02-14 2023-12-31 13F DIANTHUS THERAPEUTICS COM 252828108 33,964 33,964 353 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.